Item 1. Legal Proceedings
Item
1. Legal Proceedings
See
Note 9, Commitment and Contingencies - Legal Proceedings , of the unaudited condensed consolidated financial statements included
in this Quarterly Report, for a description of certain material legal proceedings involving the Company, which description is incorporated
herein by reference.
In the ordinary course of PAVmed business, particularly as it begins commercialization
of its products, the Company may be subject to legal actions and claims, including product liability, consumer, commercial, tax and governmental
matters, which may arise from time to time. The Company is not aware of any such pending legal or other proceedings that are reasonably
likely to have a material impact on the Company. Notwithstanding, legal proceedings are subject-to inherent uncertainties, and an unfavorable
outcome could include monetary damages, and excessive verdicts can result from litigation, and as such, could result in a material adverse
impact on the Company’s business, financial position, results of operations, and /or cash flows. Additionally, although the Company
has specific insurance for certain potential risks, the Company may in the future incur judgments or enter into settlements of claims
which may have a material adverse impact on the Company’s business, financial position, results of operations, and /or cash flows.
Item 3. Defaults Upon Senior Securities
The information set forth in Part I, Item 2 under the caption “ Liquidity and Capital Resources — Securities
Purchase Agreement - March 31, 2022 - Senior Secured Convertible Notes - April 4, 2022 and September 8, 2022 ” is incorporated
herein by reference.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.